Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.

Afsaneh ShiraniYinshan ZhaoJohn PetkauPaul GustafsonMohammad Ehsanul Karim Charity D Evans Elaine KingwellMia L van der KopJoel OgerHelen Tremlett

Published in: BioMed research international (2015)

LOMS differed clinically from AOMS. One-third of older relapsing-onset MS patients were prescribed a DMD. IFNβ exposure was not significantly associated with reduced disability in older MS patients.

Keyphrases

multiple sclerosis
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
physical activity
prognostic factors
ms ms
peritoneal dialysis
immune response
white matter
rheumatoid arthritis
patient reported
disease activity